Correlation Between Praxis Precision and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Mereo BioPharma Group, you can compare the effects of market volatilities on Praxis Precision and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Mereo BioPharma.

Diversification Opportunities for Praxis Precision and Mereo BioPharma

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Praxis and Mereo is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Praxis Precision i.e., Praxis Precision and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Praxis Precision and Mereo BioPharma

Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.99 times more return on investment than Mereo BioPharma. However, Praxis Precision Medicines is 1.01 times less risky than Mereo BioPharma. It trades about 0.03 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.17 per unit of risk. If you would invest  7,244  in Praxis Precision Medicines on August 24, 2024 and sell it today you would earn a total of  62.00  from holding Praxis Precision Medicines or generate 0.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Praxis Precision Medicines  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
Praxis Precision Med 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Praxis Precision and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Praxis Precision and Mereo BioPharma

The main advantage of trading using opposite Praxis Precision and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind Praxis Precision Medicines and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance